iFabric Corp Announces the Successful Results of the Clinical Trial Utilizing Protx2 Treated Scrubs

Stock Information for iFabric Corp.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About iFabric Corp.

iFabric Corp. Announces US EPA Registration of TWO New Cutting-Edge Antimicrobial Technologies
iFabric Corp Reports Increased Revenues for Its Financial Period Ended December 31, 2023
iFabric Corp. Provides Revenue Forecast for Fiscal 2024, Driven by Additional Customer Programs and New Performance-Apparel Categories
iFabric Announces Extension of Period to Exercise Warrants
iFabric Corp Reports Record Annual Revenues for its Financial Period Ended September 30, 2023
iFabric Corp Announces Expansion Move
iFabric Corp Announces Maidenform(R) License Renewal
iFabric Corp Update on Status of EPA Submission of PROTX2 Textile Application

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.